Skip to main content
Clinical Trials/EUCTR2006-006576-38-AT
EUCTR2006-006576-38-AT
Active, not recruiting
Not Applicable

ongitudinal imaging of serotonin transporter occupancy using PET and [11C]DASB in patients with major depression treated with escitalopram or citalopram - PET with DASB comparing escitalopram to citalopram

Siegfried KASPER, O.Univ.Prof.Dr.Dr.h.c., Medizinische Universität Wien0 sitesAugust 16, 2007

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Major depression
Sponsor
Siegfried KASPER, O.Univ.Prof.Dr.Dr.h.c., Medizinische Universität Wien
Status
Active, not recruiting
Last Updated
14 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 16, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Siegfried KASPER, O.Univ.Prof.Dr.Dr.h.c., Medizinische Universität Wien

Eligibility Criteria

Inclusion Criteria

  • Male or female
  • Age 18 – 55 years
  • DSM\-IV diagnosis of major depression
  • A score of 16 or greater on the 17\-item HAM\-D
  • Signed informed consent form
  • Negative urine pregnancy test in women at the screening visit and PET days.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range

Exclusion Criteria

  • Concomitant major medical or neurological illness
  • Clinically relevant abnormalities on a general physical examination and routine laboratory screening
  • Current substance abuse
  • Use of SSRIs or other drugs with affinity to SERT within last 3 months (or use of fluoxetine within last 4 months)
  • Any exposure to artificial radiation within 6 months prior to the inclusion into the present study

Outcomes

Primary Outcomes

Not specified

Similar Trials